DCGI gives EUA to India’s first nasal vaccine against COVID-19
BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DBT
IDRS Labs seeks emergency nod for plant-based drug against long COVID
A tripartite Memorandum of Agreement was signed among BARC, ACTREC-TMC and IDRS to develop Chlorophyllin against COVID-19 disease…
Dr Jitendra Singh inaugurates north India’s first biotech park in Kathua
Park to act as hub for incubation of new ideas, and will support agri-entrepreneurs, startups, progressive farmers, scientists and…
DBT and Ministry of AYUSH sign MoU
Through this association, it is expected that traditional healthcare and biotechnology together would enable possibilities to…
Union Minister Dr Jitendra Singh launches BioRRAP for researchers and start-ups
Speaking during the launch of Biological Research Regulatory Approval Portal (BioRRAP), Dr Singh said, India is poised to become a…
Fibroheal raises debt funding from BIRAC
The company intends to scale up its go-to-market capabilities, recruit more people on board and create an impact through the…
Dr Jyotsna Dhawan joins DBT/India Alliance as CEO
She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
India and Colombia exchange views on cooperation in biotechnology sector and vaccine tie-up
A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincón, Vice-President and Minister, Foreign Affairs, visited…
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC
The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials
Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years